Health experts accuse US FDA of taking ‘backward step’ over VLN cigarettes

The US Food and Drug Administration (FDA)’s marketing authorisation of two low-nicotine cigarettes as modified risk tobacco products including a menthol cigarette has not gone down well with public health associations or all harm reduction advocates.

The American Cancer Society Cancer Action Network (ACS CAN) fears the acceptance of 22nd Century Group’s VLN King and VLN Menthol King combustible filtered cigarettes as MRTPs is a step backwards for the protection of public health.

The association urged the agency to ban flavours in all tobacco products, including menthol in cigarettes, and to issue a product standard to make all cigarettes non-addictive.

Read full article
I'm already a subscriber

Antonia Di Lorenzo

Assistant news editor/senior reporter
Antonia is a member of the editorial team and holds a masters degree in Law from the University of Naples Federico II, Italy. She moved in 2013 to London, where she completed a postgraduate course at the London School of Journalism. In the UK, she worked as a news reporter for a financial newswire and a magazine before moving to Barcelona in 2019.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation